ALDX

Aldeyra Therapeutics, Inc.

Sales chart range
Log in to watch ALDX
Latest sale
$114k
Aug 11 · No plan
Form 4 sales
9
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleNo plan
    Oct 18 2023

    Sold 2.8M shares at $1.62 ($4.5M)

    Perceptive Life Sciences Master Fund Ltd, 10% owner

    No 10b5-1 planSold 24.3% of holdings ($18.3M position)8.6M shares leftFirst sale on recordFiling

  2. 2 Form 4 saleNo plan
    Mar 11 +145 days

    Sold 13,201 shares at $3.41 ($45k)

    Greenberg Bruce, Officer

    No 10b5-1 planSold 9.9% of holdings ($457k position)120,699 shares leftFirst sale on recordFiling

  3. 3 Form 4 saleNo plan
    Mar 12 +1 day

    Sold 183,238 shares at $3.17 ($580k)

    Brady Todd C, President and CEO

    No 10b5-1 planSold 11.1% of holdings ($5.2M position)1.5M shares leftFirst sale on recordFiling

  4. 4 Form 4 saleNo plan
    Mar 12 same day

    Sold 29,768 shares at $3.31 ($99k)

    Machatha Stephen, Chief Development Officer

    No 10b5-1 planSold 10.9% of holdings ($905k position)243,495 shares leftFirst sale on recordFiling

  5. 5 Form 4 saleNo plan
    Aug 12 +153 days

    Sold 10,834 shares at $4.74 ($51k)

    Greenberg Bruce, Officer

    No 10b5-1 planSold 7.9% of holdings ($650k position)126,382 shares leftFiling

  6. 6 Form 4 saleNo plan
    Aug 12 same day

    Sold 16,041 shares at $4.74 ($76k)

    Machatha Stephen, Chief Development Officer

    No 10b5-1 planSold 6.3% of holdings ($1.2M position)236,771 shares leftFiling

  7. 7 Form 4 saleUnusual
    Apr 3 +234 days

    Sold 3.4M shares at $1.42 ($4.8M)

    Perceptive Life Sciences Master Fund Ltd, 10% owner

    No 10b5-1 planSold 36.7% of holdings ($13.2M position)5.9M shares leftFiling

  8. 8 Form 4 saleNo plan
    Aug 11 +130 days

    Sold 22,073 shares at $5.15 ($114k)

    Machatha Stephen, Chief Development Officer

    No 10b5-1 planSold 9.1% of holdings ($1.3M position)221,799 shares leftFiling

Every transaction

Loading transactions…

Sales, notices and lockups (9)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for ALDX
Source
Aug 11, 2025Machatha StephenChief Development OfficerForm 4 sale22,073$114k9.1%No planSEC
Apr 3, 2025Perceptive Life Sciences Master Fund Ltd10% ownerForm 4 sale3.4M$4.8M36.7%UnusualSEC
Aug 12, 2024Machatha StephenChief Development OfficerForm 4 sale16,041$76k6.3%No planSEC
Aug 12, 2024Greenberg BruceOfficerForm 4 sale10,834$51k7.9%No planSEC
Mar 12, 2024Machatha StephenChief Development OfficerForm 4 sale29,768$99k10.9%No planSEC
Mar 12, 2024Brady Todd CPresident and CEOForm 4 sale183,238$580k11.1%No planSEC
Mar 11, 2024Greenberg BruceOfficerForm 4 sale13,201$45k9.9%No planSEC
Oct 18, 2023Perceptive Life Sciences Master Fund Ltd10% ownerForm 4 sale2.8M$4.5M24.3%No planSEC
Mar 26, 2019Treu Jesse IDirectorForm 4 sale96,743$968k91.7%UnusualSEC